KARTALCI, Ş. Et Al. 2016. IL-4, TGF-beta, NF-kappa B and MPO levels in Patients with Treatment Resistant Schizophrenia. TURK PSIKIYATRI DERGISI , vol.27, no.3 , 170-175.

KARTALCI, Ş., Erbay, L. G., ZAYMAN, E. P., OTLU, O., KARABULUT, A. B., & KARTALCI, G., (2016). IL-4, TGF-beta, NF-kappa B and MPO levels in Patients with Treatment Resistant Schizophrenia. TURK PSIKIYATRI DERGISI , vol.27, no.3, 170-175.

KARTALCI, ŞÜKRÜ Et Al. "IL-4, TGF-beta, NF-kappa B and MPO levels in Patients with Treatment Resistant Schizophrenia," TURK PSIKIYATRI DERGISI , vol.27, no.3, 170-175, 2016

KARTALCI, ŞÜKRÜ Et Al. "IL-4, TGF-beta, NF-kappa B and MPO levels in Patients with Treatment Resistant Schizophrenia." TURK PSIKIYATRI DERGISI , vol.27, no.3, pp.170-175, 2016

KARTALCI, Ş. Et Al. (2016) . "IL-4, TGF-beta, NF-kappa B and MPO levels in Patients with Treatment Resistant Schizophrenia." TURK PSIKIYATRI DERGISI , vol.27, no.3, pp.170-175.

@article{article, author={ŞÜKRÜ KARTALCI Et Al. }, title={IL-4, TGF-beta, NF-kappa B and MPO levels in Patients with Treatment Resistant Schizophrenia}, journal={TURK PSIKIYATRI DERGISI}, year=2016, pages={170-175} }